TRL Relative Valuation - DaVita Inc

Watchlist Manager

Watchlist

Price: 125.75 EUR -3.23% Market Closed

Market Cap: €11B

D	DaVita Inc F:TRL	US
L	Ludan Engineering Co Ltd TASE:LUDN	IL
	Rohto Pharmaceutical Co Ltd TSE:4527	JP

Multiples-Based Value

The Multiples-Based Value of one TRL stock under the Base Case scenario is 276.96 EUR. Compared to the current market price of 125.75 EUR, DaVita Inc is Undervalued by 55%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

TRL Multiples-Based Value

Base Case

Undervaluation 55%

Multiples-Based Value

Price €125.75

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		DaVita Inc F:TRL	10B EUR	0.7	13.4	7	9.5
US		CVS Health Corp NYSE:CVS	93.4B USD	0.2	52.8	13.7	13.7
US	C	Cigna Group XMUN:CGN	67.2B EUR	0.3	13.1	7.7	9.8
US		Cigna Corp NYSE:CI	71.1B USD	0.3	11.9	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.5B EUR	1.1	19.4	9.2	13.8
DE		Fresenius Medical Care AG XMUN:FME	22.5B EUR	1.1	23	8.9	16.5
US		Laboratory Corporation of America Holdings NYSE:LH	22.5B USD	1.6	25.6	12.3	17.8
US		Quest Diagnostics Inc NYSE:DGX	21.8B USD	2	22	11.9	16.1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.8B EUR	0.6	11	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	12.3B USD	12.5	-29.4	-32.2	-29.2
US		Brightspring Health Services Inc NASDAQ:BTSG	8.3B USD	0	0	0	0

				Revenue Growth	P/S to Growth
US		DaVita Inc F:TRL	Average P/S: 2 0.7	4%	0.2
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.1	2%	0.6
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	2%	0.3
US		Guardant Health Inc NASDAQ:GH	12.5	29%	0.4
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	15%	N/A

				Earnings Growth	PEG
US		DaVita Inc F:TRL	Average P/E: 21.4 13.4	20%	0.7
US		CVS Health Corp NYSE:CVS	52.8	90%	0.6
US	C	Cigna Group XMUN:CGN	13.1	19%	0.7
US		Cigna Corp NYSE:CI	11.9	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.4	26%	0.7
DE		Fresenius Medical Care AG XMUN:FME	23	16%	1.4
US		Laboratory Corporation of America Holdings NYSE:LH	25.6	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.4	N/A	N/A
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	30%	N/A

				EBITDA Growth	EV/EBITDA to Growth
US		DaVita Inc F:TRL	Average EV/EBITDA: 9.5 7	4%	1.8
US		CVS Health Corp NYSE:CVS	13.7	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.2	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	8.9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.3	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.9	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -32.2	N/A	N/A
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	31%	N/A

				EBIT Growth	EV/EBIT to Growth
US		DaVita Inc F:TRL	Average EV/EBIT: 13.4 9.5	5%	1.9
US		CVS Health Corp NYSE:CVS	13.7	22%	0.6
US	C	Cigna Group XMUN:CGN	9.8	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.8	12%	1.1
DE		Fresenius Medical Care AG XMUN:FME	16.5	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.8	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16.1	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.2	N/A	N/A
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	43%	N/A

DaVita Inc
F:TRL

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

TRL Competitors Multiples
DaVita Inc Competitors

See Also

Company

Help

Tools

Stocks

DaVita Inc F:TRL

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

TRL Competitors Multiples DaVita Inc Competitors

See Also

Company

Help

Tools

Stocks

DaVita Inc
F:TRL

TRL Competitors Multiples
DaVita Inc Competitors